BamSEC and AlphaSense Join Forces
Learn More

Carisma Therapeutics Inc.

NASDAQ: CARM    
Share price (1/8/25): $0.47    
Market cap (1/8/25): $19.8 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 42 pages Amended and Restated Open Market Sale Agreementsm
12/34/56
EX-1.1
from 8-K 4 pages Underwriting agreement
12/34/56
EX-1.1
from 8-K 4 pages Underwriting agreement
12/34/56
EX-1
from 8-K 4 pages Underwriting agreement
12/34/56
EX-1.1
from 8-K 68 pages 20,410,000 Shares of Common Stock and Warrants to Purchase Up to 20,410,000 Shares of Common Stock Sesen Bio, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages 22,222,223 Shares Sesen Bio, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 14 pages Underwriting agreement
12/34/56
EX-1.1
from 8-K 79 pages 5,525,000 Shares of Common Stock Pre-Funded Warrants to Purchase 4,475,000 Shares of Common Stock and Warrants to Purchase 10,000,000 Shares of Common Stock Eleven Biotherapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 36 pages [•] Shares of Common Stock (Or Pre-Funded Warrants to Purchase Shares of Common Stock in Lieu Thereof) and Warrants to Purchase [•] Shares of Common Stock Eleven Biotherapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 36 pages [•] Shares of Common Stock (Or Pre-Funded Warrants to Purchase Shares of Common Stock in Lieu Thereof) and Warrants to Purchase [•] Shares of Common Stock Eleven Biotherapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 33 pages [•] Shares Eleven Biotherapeutics, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.2
from S-3 34 pages Eleven Biotherapeutics, Inc. Up to $40,000,000 of Shares of Common Stock Sales Agreement
12/34/56
EX-1.1
from S-1/A 39 pages Eleven Biotherapeutics, Inc
12/34/56